Klinische Monatsblatter fur Augenheilkunde · 1994
[Results of cyclocryocoagulation].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Meyer J H, Soriano J M, Janknecht P, Funk J
Аннотация
BACKGROUND: The success of a cyclocryocogulation is not only defined by the reduction of the intraocular pressure but also by the simplification of the therapy necessary for the regulation of the glaucoma.
PATIENTS: We examined retrospectively the charts of 27 patients with glaucoma chronicum simplex (GCS) and 63 patients with various types of non-simplex glaucomas (NGCS). All underwent a cyclocryocoagulation made 51 seconds at -70 to -80 degrees C, 4 mm behind the limbus at 6 points.
RESULTS: IOP was controlled (i.e. < 25 mm Hg and decreased > 20% of the preoperative value) in 69% of the cases (GCS 70%, NGCS 68%) 3-5 days after the operation. IOP decreased from 31 to 19 mm Hg on average. The effect decreased with time, more than 12 months after the operation only 36% of the eyes were still regulated. 4 eyes with persisting pain had to be enucleated. The cyclocryocoagulation never caused blindness or phthisis bulbi. Therapy with eye drops was necessary in 70% of the patients preoperatively, and in 37% postoperatively. Oral carboanhydrase inhibitors had to be used in 57% of the patients before and in 20% of the cases after the operation.
CONCLUSION: Cyclocryocoagulation is considered an effective method to lower IOP and simplify drug therapy without having serious complications.
PATIENTS: We examined retrospectively the charts of 27 patients with glaucoma chronicum simplex (GCS) and 63 patients with various types of non-simplex glaucomas (NGCS). All underwent a cyclocryocoagulation made 51 seconds at -70 to -80 degrees C, 4 mm behind the limbus at 6 points.
RESULTS: IOP was controlled (i.e. < 25 mm Hg and decreased > 20% of the preoperative value) in 69% of the cases (GCS 70%, NGCS 68%) 3-5 days after the operation. IOP decreased from 31 to 19 mm Hg on average. The effect decreased with time, more than 12 months after the operation only 36% of the eyes were still regulated. 4 eyes with persisting pain had to be enucleated. The cyclocryocoagulation never caused blindness or phthisis bulbi. Therapy with eye drops was necessary in 70% of the patients preoperatively, and in 37% postoperatively. Oral carboanhydrase inhibitors had to be used in 57% of the patients before and in 20% of the cases after the operation.
CONCLUSION: Cyclocryocoagulation is considered an effective method to lower IOP and simplify drug therapy without having serious complications.